News

Novartis spend on digital and data ‘in the 100s of millions’

Novartis spend on digital and data ‘in the 100s of millions’

In its annual results briefing in Basel, Switzerland, Novartis emphasised the integration of digital and data into the way the company works, claiming to be spending ‘in the 100s of millions’ on collating its ‘goldmine’ of more than two million patient years of clinical trial data.

Kymriah gets NICE approval for DLBCL

Kymriah gets NICE approval for DLBCL

The National Institute for Health and Care Excellence (NICE) has approved Novartis’ chimeric antigen receptor T-cell (CAR T-cell) therapy Kymriah for treatment of adults with diffuse large B-cell lymphoma (DLBCL).

Greater Manchester to trial digital service for heart failure

Greater Manchester to trial digital service for heart failure

A new digitally-enhanced service for people with heart failure is to be trialled in Greater Manchester, where around 1,000 patients’ data from existing implantable devices will be used to transform care and better meet their needs.

NHS England unveils five-year deal to expand GP services

NHS England unveils five-year deal to expand GP services

NHS England has announced the launch of a new five-year contract for general practice across England, which will see billions of pounds of extra investment for improved access to family doctors, expanded services at local practices and longer appointments for patients who need them.

ABPI warns over skills shortages

ABPI warns over skills shortages

The Association of the British Pharmaceutical Industry is warning that the UK needs to fill an increasing number of science skills gaps in order to retain its prominent position for medicines and vaccines research and development.

NICE links with EMIG

NICE links with EMIG

The National Institute for Health and Care Excellence and the Ethical Medicines Industry Group (EMIG) are working together to increase understanding of the services the Institute offers the life sciences industry.